Apollomics, Inc. (APLM) vs TELA Bio, Inc. (TELA)
A side-by-side comparison of Apollomics, Inc. and TELA Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.55HealthcareDelayed quote: Oct 6, 2026, 2:18 PM EDT
TELA
TELA Bio, Inc.
$1.10HealthcareDelayed quote: Oct 6, 2026, 2:13 PM EDT
Total return — APLM vs TELA
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)TELA -90.7% (-37.8%/yr)TELA compounded faster over this window
APLM TELA
APLM vs TELA: by the numbers
- •APLM is the larger company ($50M vs $49M market cap).
- •Both run net losses; TELA's is the smaller (-51.53% vs -128.69% net margin).
- •APLM grew revenue faster over the past five years (35.84% vs 26.77% CAGR).
Metrics side by side
Valuation
| Metric | APLM | TELA |
|---|---|---|
| P/S ratio | N/A | 0.62 |
Profitability
| Metric | APLM | TELA |
|---|---|---|
| Gross margin | 97.00% | 67.81% |
| Operating margin | -111.45% | -42.56% |
| Net margin | -128.69% | -51.53% |
| ROIC | -2441.49% | -80.88% |
Growth (annualized)
| Metric | APLM | TELA |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | 26.77% |
| Total return CAGR (5Y) | N/A | -38.71% |
Frequently asked
- Which has grown faster, APLM or TELA?
- Over the past five years, APLM grew revenue faster — APLM at a 35.84% CAGR versus TELA at 26.77%.
Go deeper
Dig into the metrics
Apollomics ROETELA Bio ROEApollomics operating marginTELA Bio operating marginApollomics revenue growthTELA Bio revenue growthApollomics free cash flowTELA Bio free cash flow
Apollomics & TELA Bio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.